08:11 EST Cogent Biosciences (COGT) up 10% at $8.14 after disclosing insider buy
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COGT:
- Cogent Biosciences price target lowered to $14 from $17 at H.C. Wainwright
- Cogent Biosciences highlighted key 2025 milestones
- Cogent Biosciences downgraded to Hold from Buy at Needham
- Cogent Biosciences announces updates results from SUMMIT
- Cogent Biosciences announces updated data from ongoing Phase 2 APEX trial